Skip to Content

Publications

Network Publications

Recent Publications by GAP's Network

Chromosome 7p11.2 (EGFR) variation influences glioma risk. Sanson, Mark; Shete, Sanjay; Förssti, Asti; Simon, Mathias; et., al. MD Anderson and German Cancer Research Center (DKFZ).

Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: A population based study. Chien, Chun Ru; Su, Shan-Yu; Cohen, Lorenzo; Lin, Hsiang-Wen; Lee, Richard Tsong; Shih, Ya-Chen (Tina). MD Anderson and China Medical University Hospital, China Medical University, Taichung, Taiwan.

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Yang, Jilong; Yang, Da; Sun, Yan; Sun, Baocun; Wang, Guowen; Trent, Jonathan; Araujo, Dejka; Chen, Kexin; Zhang, Wei. MD Anderson and Tianjin Medical University Cancer Hospital and Institute, Tianjin, China.

Overcoming Trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Zhao, Yuhua; Liu, Hao; Liu, Zixing; Ding, Yan; LeDous, Susan P; Wilson, Glenn L; Voellmy, Richard; Lin, Yifeng; Lin, Wensheng; Nahta, Rita; Liu, Bolin; Fodstad, Øystein; Chen, Jieqing; Wu, Yun; Price, Janet E; Tan, Ming. MD Anderson and Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

MicroRNA history: discovery, recent applications and next frontiers. Almeida, Maria I.; Reis, Rui M.; Calin, George A. MD Anderson and Barretos Cancer Hospital, Barretos, Brazil.

A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus. Yu, Wen; Fu, Xiao-Long; Zhang, Ying-Jian; Xiang, Jia-Qing; Shen, Lei; Chang, Joe Y. MD Anderson and Fudan University Cancer Hospital, Fudan, China. 

Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. Leong, Stanly; Zuber, Markus; Ferris, Robert; Kitagawa, Yuko; Cabanas, Ramon; Levenback, Charles; Faries, Mark; Saha, Sukamal. MD Anderson and Keio University School of Medicine, Tokyo, Japan.

Multifactorial approach to predicting resistance to anthracyclines.
Desmedt, Christine; Di Leo, Angelo; de Azambuja, Evandro; Larsimont, Denis; Haibe-Kains, Benjamin; Selleslags, Jean; Delaloge, Suzette; Duhem, Caroline; Kains, Jean-Pierre; Carly, Birgit; Maerevoet, Marie; Vindevoghel, Anita; Rouas, Ghislane; Lallemand, Françoise; Durbecq, Virginie; Cardoso, Fatima; Salgado, Roberto; Rovere, Rodrigo; Bontempi, Gianluca; Michiels, Stefan; Buyse, Marc; Nogaret, Jena-Maire; Qi, Yuan; Symmans, Fraser; Pusztai, Lajos; D'Hondt, Véronique; Piccart-Gebhart, Martine; Sotiriou, Christos. MD Anderson and Institut Gustave Roussy, Villejuif, France.

Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating preoxisome proliferator-activated receptor γ-2. Chen, Ya-Huey; Yeh, Fang-Ling; Yeh, Su-Peng; Ma, Haou-Tzong; Hung, Shih-Chieh; Hung, Mien-Chie; Li, Long-Yuan. MD Anderson and China Medical University and Hospital, Taichung, Taiwan.

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. Cheng, Hanyin; Zhang, Lina; Cogdell, David E.; Zheng, Hong; Schetter, Aaron J.; Nykter, Matti; Harris, Curtis C.; Chen, Kexin; Stanley R. Hamilton; Zhang, Wei. MD Anderson and Tianjin Medical Univeristy Cancer Institute and Hospital, Tianjin, China.

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. Øvestad, Irene Tveiterås; Gudlaugsson, Einar; Skaland, Ivar; Malpica, Anais; Munk, Ane Cecilie; Janssen, Emiel AM; Baak, Jan P. MD Anderson and Stavanger University Hospital, Stavanger, Norway.

Economic burden of renal cell carcinoma: Part 1 - An updated review. Shih, Ya-Chen T.; Chien, Chun-Ru; Pan, I-Wen; Smith, Grace L.; Buchholtz, Thomas A. MD Anderson and China Medical University Hospital, Taichung, Taiwan.

Economic burden of renal cell carcinoma: Part II - An updated analysis. Shih, Ya-Chen T.; Chien, Chun-Ru; Xu, Ying; Pan, I-Wen; Smith, Grace L.; Buchholtz, Thomas A. MD Anderson and China Medical University Hospital, Taichung, Taiwan.

Triple-negative breast cancer in hispanic patients. Lara-Medina, Fernando; Pérez-Sánchez, Victor; Saavedra-Pérez, David; Blake-Cerda, Monika; Arce, Claudia; Motola-Kuba, Daniel; Villareal-Garza, Cynthia; González-Angulo, Ana Maria; Bargalló, Enrique; Aguillar, Jose Luis; Mohar, Alejandro; Arrieta, Óscar. MD Anderson and National Cancer Institute (INCan) Mexico City, Mexico.

WIN Consortium -- challenges and advances. Mendelsohn, John; Tursz, Thomas; Shilsky, Richard L.; Lazar, Vladimir. MD Anderson and Institut Gustave Roussy.

Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate. Rodeberg, David A.; Anderson, James R.; Arndt, Carola A.; Ferrer, Fernando A.; Beverly Raney, Richard; Jenney, Meriel E.; Brech, Ines B.; Koscielniak, Ewa; Carli, Modesto; Bisogno, Gianni; Oberlin, Odile; Rey, Annie; Ultrich, Fred; Stevens, Michael C. G.; Meyer, William H. MD Anderson and Institut Gustave Roussy, Villejuif, France.

Biomarker studies: call for a comprehensive biomarker study registry. Andre, Fabrice; McShane, Lisa M.; Michiels, Stefan; Ransohoff, David F.; Altman, Douglas G.; Reis-Filho, Jorge S.; Hayes, Daniel F.; Pusztai, Lajos. MD Anderson and Institut Gustave Roussy, Villejuif, France.

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer. Zhang, Hui; Slewa, Aida; Janssen, Emiel; Skaland, Ivar; Yu, Yinhua; Gudlaugsson, Einar; Feng, Weiwei; Kjellevold, Kjell; Søiland, Hävard; Baak, Jan P.A. MD Anderson and Stavanger University Hospital, Stavanger, Norway.

Myeloablative reduced-toxicity IV busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. Gheath Alatrash, Marcos de Lima, Nelson Hamerschlak, Matteo Pelosini, Xuemei Wang, Lianchun Xiao, Fabio Kerbauy, Alexandre Chiattone, Gabriela Rondon, Muzaffar H. Qazilbash, Sergio A. Giralt, Leandro de Padua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Yago Nieto, Rima M. Saliba, Richard E. Champlin and Borje S. Andersson. MD Anderson and Hospital Israelita Albert Einstein, São Paulo, Brazil.

Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. Ramy F. Youssef, Shahrokh F. Shariat, Yair Lotan, Christopher G. Wood, Arthur I. Sagalowsky, Richard Zigeuner, Eiji Kikuchi, Alon Weizer, Jay D. Raman, Mesut Remzi, Wareef Kabbani, Cord Langner, Charles C. Guo, Marco Roscigno, Francesco Montorsi, Christian Bolenz, Wassim Kassouf, Vitaly Margulis. MD Anderson and Keio University School of Medicine, Tokyo, Japan.

New drugs for Chronic Myelogenous Leukemia. Fabio P.S. Santos, Alfonsos Quintás-Cardama. MD Anderson and Hospital Israelita Albert Einstein, São Paulo, Brazil.

Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Giridhar Mudduluru, Jonahunnatha Nesson George-William, Santoshi Muppala, Irfan, Ahmed Asangani, Kumarswamy Regalla, Laura D Nelson, and Heike Allgayer. MD Anderson and German Cancer Research Center, DKFZ, Heidelberg, Germany.

The Biphasic Role of NF-κB in Tumor Progression and Chemoresistance of Ovarian Cancer. Gong Yang, Xue Xiao, Daniel Rosen, Xi Cheng, Xiaohua Wu, Bin Chang, Guangzhi Liu, Fengxia Xue, Imelda Mercado-Uribe, Paul J Chiao, Xiang Du, and Jinsong Liu. MD Anderson and Fudan University Shanghai Cancer Center, Fudan, China.

Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. Ramy F. Youssef, Shahrokh F. Shariat, Yair Lotan, Christopher G. Wood, Arthur I. Sagalowsky, Richard Zigeuner, Eiji Kikuchi, Alon Weizer, Jay D. Raman, Mesut Remzi, Wareef Kabbani, Cord Langner, Charles C. Guo, Marco Roscigno, Francesco Montorsi, Christian Bolenz, Wassim Kassouf, Vitaly Margulis. MD Anderson and Keio University School of Medicine, Tokyo, Japan

New drugs for chronic myelogenous leukemia. A. Quintás-Cardama, FPS Santos. MD Anderson and Hospital Israelita Albert Einstein, São Paulo, Brazil.

Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers
Ruiying Zhao, Sai-Ching J.Yeung, Jian Che1, Tomoo Iwakuma, Chun-Hui Su, Bo Chen, Changju Qu, Fanmao Zhang, You-Tzung Chen, Yu-Li Lin, Dung-Fang Lee, Feng Jin, Rui Zhu, Tattym Shaikenov, Dos Sarbassov, Aysegul Sahin, Huamin Wang, Hua Wang, Chien-Chen Lai, Fuu-Jen Tsai, Guillermina Lozano and Mong-Hong Lee. MD Anderson and China Medical University Hospital, Taichung, Taiwan.

Cancer-targeted BikDD gene therapy elicits protective anti-tumor immunity against lung cancer: Yuh-Pyng Sher, Shih-Jen Liu, Chun-Mien Chang, Shu-Pei Lien, Chien-Hua Chen, Zhenbo Han, Long-Yuan Li, Jin-Shing Chen, Cheng-Wen Wu and Mien-Chie Hung. MD Anderson and China Medical University, Taichung, Taiwan.

Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy: X. Chenga, G. Yang, K.M. Schmelera, R.L. Colemana, X. Tuc, J. Liub and J.J. Kavanagha. MD Anderson and Fudan University Cancer Hospital, Fudan, China.


© 2014 The University of Texas MD Anderson Cancer Center